Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Imprimis NJOF, LLC recalls Dexamethasone Moxifloxacin Ketorolac

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of particulate matter - Glass like particles.
Products
  • Dexamethasone Moxifloxacin Ketorolac
Where it was sold

U.S Nationwide

Nationwide

Units affected
596 boxes of 11,920 pre-filled syringes
About this recall
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.